Latest News

Vision
Prism will become a leading specialty pharmaceutical company committed to developing and commercializing acute care cardiovascular products.

Focus
Prism is focused on recognizing unfulfilled opportunities in existing compounds that target acute care cardiovascular needs and comprehensively developing them to achieve their full market potential.

Approach
Through smart selection of compounds, Prism creates unique and valid development pathways shaped by medical need and market opportunity. Our business model is engineered and financed to aggressively acquire, develop, and commercialize products to achieve market leadership.

Our seasoned management team has decades of commercial and drug development expertise that allow Prism to efficiently and cost-effectively evaluate product development concepts and marketplace opportunities while managing commercial and regulatory risk.